Enabling statisticians to lead through innovation and excellence - sponsored by PSI
Have you ever felt bad about talking about your achievements? Did you ever thought, that you’re just doing your job, when you accomplished something? Did you ever feel, that others didn’t understand, how significant your contribution was?
If your answer to any of these questions is yes, this episode is for you!
[Read more…] about How to sell your achievements – actionable adviseAlex Dmitrienko has researched and published so much, that without a doubt, he can be called one of the world class experts in the field of multiplicity. E.g. his book Multiple Testing Problems in Pharmaceutical Statistics contains a wealth of practical information on this topic.
His career has brought him from pharma over CROs to his own company Mediana. Via his company, he provides also online courses on his favourite topic. Please access these here!
In part 2 of this interview with Walt Offen, we cover:
[Read more…] about 20 key attributes of highly successful leaders – lessons from Walt Offen – part 2In this episode, I have the privilege to interview Walt Offen – a statistician who is about to end an amazing career over a couple of decades of working in the pharmaceutical industry.
Walt organized together, what he believes to be the 20 key attributes of highly successful leaders. They are organized in no particular order but are enriched with great stories.
[Read more…] about 20 key attributes of highly successful leaders – lessons from Walt Offen – part 1In this very short episode, I’m stepping back from the day-to-day business and reflect about why we go to work every day.
I have a very personal story about it, that helped me to see things very clearly and I’m sharing this in this episode.
Further, many of you will listen this during vacation time and thus, I’m also touching on the importance of taking a break.
There is no episode next week as we take a summer break as well.
[Read more…] about Vacation episode 2018 – some thoughts about why we do what we do
Indirect comparisons provide evidence, when no direct clinical trials are available. However, the different approaches come with various limitations. Some more recent approaches take into account the baseline characteristics to reduce the bias in the estimates of the treatment effects.
In todays episode, I’m talking with one the worlds experts on this topic – Nicky Welton – who has published extensively in this field. [Read more…] about Multilevel Network Meta-Regression for population-adjusted treatment comparisons – Interview with Nicky Welton
